To include your compound in the COVID-19 Resource Center, submit it here.

BioSante, John P. Hussman Foundation deal

The foundation received exclusive, worldwide rights to BioSante's GVAX melanoma vaccine

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE